Belantamab mafodotin

CAT: 0804-HY-P3239-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P3239-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Belantamab mafodotin (GSK2857916) is composed of humanized and focused monoclonal antibody against B cell maturation antigen (BCMA) and McMMAF. The antibody portion is Belantamab (HY-P9980), and the drug-linker conjugate for ADC is McMMAF (HY-15578) . Belantamab mafodotin has anti-myeloma activity[1][2].
CAS Number
[2050232-20-5]
Product Name Alternative
GSK2857916; Belantamab mafodotin-blm
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/belantamab-mafodotin.html
Purity
99.78
Solubility
10 mM in DMSO
Smiles
[Belantamabmafodotin]
Molecular Weight
149000 (average)
References & Citations
[1]Hulin C, et al. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2) : a two-arm, randomised, open-label, phase 2 study. Lancet Oncol. 2020 Feb;21 (2) :207-221.|[2]Markham A. Belantamab Mafodotin: First Approval. Drugs. 2020 Oct;80 (15) :1607-1613.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Launched

Popular Products